Skip to main content

Rubedo Life Sciences

Sunnyvale, United States

Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.

$40.0M raised
Apr 2024
Series A

Top Investors

Alumni VenturesKhosla VenturesAhren Innovation CapitalRefactorModi Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Rubedo Life Sciences

How much funding has Rubedo Life Sciences raised?
Rubedo Life Sciences has raised $40.0M in total funding. The most recent round was Series A. The last funding was announced in April 2024.
Who are Rubedo Life Sciences's investors?
Rubedo Life Sciences's investors include Alumni Ventures, Khosla Ventures, Ahren Innovation Capital, Refactor, Modi Ventures.
Where is Rubedo Life Sciences headquartered?
Rubedo Life Sciences is headquartered in Sunnyvale, United States.
What does Rubedo Life Sciences do?
Rubedo Life Sciences focuses on developing medicines that target the specific cells responsible for aging, known as pathologic cells.
What stage is Rubedo Life Sciences at?
Rubedo Life Sciences is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Rubedo Life Sciences — Funding & Investors." VCBacked, April 22, 2024, https://www.vcbacked.co/company/rubedo-life-sciences. Accessed June 17, 2026.
APA
VCBacked. (2024). Rubedo Life Sciences — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/rubedo-life-sciences
Wikipedia (cite web)
{{cite web |title=Rubedo Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/rubedo-life-sciences |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .